On June 5. 2025. Chemspec Europe 2025. an important event in the European chemical and pharmaceutical sectors, successfully concluded in Cologne, Germany. Laviana Pharma showcased its innovative green synthesis technology and comprehensive CDMO solutions in Cologne, attracting potential clients and partners from Europe, North America, and the Asia-Pacific region for discussions, resulting in multiple cooperation intentions and injecting new momentum into the low-carbon transformation of the global pharmaceutical industry chain.

As a pioneer in the CDMO field with over 20 years of deep cultivation, Laviana Pharma showcased its core competitiveness at this exhibition. In terms of green synthesis technology, the company employs cutting-edge methods such as catalytic technology and continuous flow reactions to effectively reduce production energy consumption and waste emissions, providing practical solutions for transforming production towards efficiency and low carbon, leading the industry's green transformation trend. Its capability in complex molecule development is also noteworthy, with services covering the entire process from preclinical research, process development, to pilot production and commercial approval for small molecule innovative drugs, particularly achieving key technological breakthroughs in the field of high-purity pharmaceutical intermediates, laying a solid foundation for innovative drug research and development. Furthermore, Laviana Pharma can customize end-to-end service solutions based on clients' personalized needs, significantly shortening drug development cycles and helping clients quickly seize market opportunities.

In recent years, Laviana Pharma has been continuously accelerating its global layout. The newly established European branch and the US formulation laboratory, supported by a professional formulation team, have further enhanced the company's responsiveness and service level in the global pharmaceutical market.

At the exhibition site, the Laviana Pharma team engaged in in-depth communication with overseas clients from around the world, sharing the successful outcomes of several representative projects delivered recently. They also conducted in-depth discussions on the development trends of the global pharmaceutical industry and future cooperation opportunities. The impressive performance at this exhibition fully demonstrated Laviana Pharma's technical strength and innovative vitality, laying a solid foundation for further expanding international markets and deepening global cooperation. In the future, Laviana Pharma will continue to uphold the innovation-driven development concept, contributing to the high-quality development of the global pharmaceutical industry with better technology and services.